Table 1 Research Subjects Participating in the Three Study Phases.
From: T cells display mitochondria hyperpolarization in human type 1 diabetes
Phase | Participant Group | n | Age [Years(Medianrange)] | Gender [% Female] | Disease Duration [Years (Median, range)] | HbA1C [%] |
|---|---|---|---|---|---|---|
1 | 67 | |||||
Type 1 diabetes | 29 | 14, 9–27 | 55% | 5.6, 0.1–18.6 | 7.1–14.6 | |
Healthy control | 38 | 16, 7–38 | 42% | N/A | ND | |
2 | 107 | |||||
Type 1 diabetes | 25 | 12, 4–60 | 44% | 2.67, 0.08–18 | ND | |
Healthy Control | 21 | 33.5, 19–51 | 52% | N/A | ND | |
Type 2 diabetes | 1 | 45 | 100% | ND | ||
1st Degree Relative | 53 | 30, 4–56 | 60% | |||
2nd Degree Relative | 7 | 60, 50–66 | 86% | |||
3 | 93 | |||||
Type 1 diabetes | 39 | 18, 6.8–61 | 51% | 8, 0.08–35.1 | 9.9–14 | |
Healthy control | 34 | 22.5, 7–53 | 62% | ND | ||
Type 2 diabetes | 20 | 34.5, 10.6–66 | 65% | 3.25, 0.08–22 | 4.8–14 | |
Functional Studies | 137 | |||||
All Phase 3 | 93 | |||||
Healthy control | 3 | 44, 22–45 | 67% | ND | ||
1st Degree Relative | 40 | 32.5, 8–61 | 48% | ND | ||
Type 2 diabetes | 1 | 0% | ND |
